Literature DB >> 7981229

Leukotriene C4 upregulates collagenase expression and synthesis in human lung fibroblasts.

L Medina1, J Pérez-Ramos, R Ramírez, M Selman, A Pardo.   

Abstract

Leukotriene C4 (LTC4), a mediator generated by a variety of inflammatory cells, participates in several physiological and pathological processes. It has been shown that LTC4 stimulates collagen synthesis by fibroblasts, suggesting a role in collagen turnover. However, the possible effect of this mediator on collagen degradation has not been examined. In this study we explored the role of LTC4 in the modulation of fibroblast interstitial collagenase and TIMP-1. Confluent cultures of three human normal lung fibroblast cell lines, and one derived from idiopathic pulmonary fibrosis (IPF) were exposed to LTC4 0.1, 1 and 10 nM, and to IL-1 beta as positive control. Collagenase and TIMP mRNAs expression were analyzed by Northern blot followed by densitometric scanning. Immunoreactive procollagenase was detected by immunoblot, and collagenase activity was measured using [3H]collagen. Our results showed that LTC4 enhanced several-fold collagenase mRNA expression in collagenase-producing fibroblasts, and induced the expression of the enzyme mRNA in collagenase-nonproducing fibroblasts, both in normal and IPF derived cell lines. LTC4 1 nM induced the highest response. Collagenolytic activity and immunoreactive collagenase paralleled collagenase mRNA expression. Interestingly, simultaneous exposure of fibroblasts to LTC4 plus IL-1 failed to show additive effects. Moreover, in two cell lines the combination resulted in a decrease of collagenase mRNA expression compared with both mediators separately. TIMP mRNA levels were not significantly modified by LTC4, nor IL1 beta. Our findings suggest that LTC4 plays a role in the modulation of fibroblast collagenase, and it may participate in extracellular matrix remodeling during lung inflammation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981229     DOI: 10.1016/0167-4889(94)90187-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  5-Lipoxygenase-activating protein (FLAP) inhibitor MK-0591 prevents aberrant alveolarization in newborn mice exposed to 85% oxygen in a dose- and time-dependent manner.

Authors:  Min Soo Park; Myung Hyun Sohn; Kyu-Earn Kim; Moon Sung Park; Ran Namgung; Chul Lee
Journal:  Lung       Date:  2010-11-05       Impact factor: 2.584

2.  Collagenase-3 induction in rat lung fibroblasts requires the combined effects of tumor necrosis factor-alpha and 12-lipoxygenase metabolites: a model of macrophage-induced, fibroblast-driven extracellular matrix remodeling during inflammatory lung injury.

Authors:  T J Mariani; S Sandefur; J D Roby; R A Pierce
Journal:  Mol Biol Cell       Date:  1998-06       Impact factor: 4.138

3.  Exhaled breath condensate cysteinyl leukotrienes and airway remodeling in childhood asthma: a pilot study.

Authors:  Christiane Lex; Angela Zacharasiewicz; Donald N R Payne; Nicola M Wilson; Andrew G Nicholson; Sergei A Kharitonov; Peter J Barnes; Andrew Bush
Journal:  Respir Res       Date:  2006-04-07

Review 4.  Leukotriene receptors in rhinitis and sinusitis.

Authors:  John W Steinke; Larry Borish
Journal:  Curr Allergy Asthma Rep       Date:  2004-05       Impact factor: 4.919

5.  Arachidonic acid increases matrix metalloproteinase 9 secretion and expression in human monocytic MonoMac 6 cells.

Authors:  Tiina Solakivi; Tarja Kunnas; Satu Kärkkäinen; Olli Jaakkola; Seppo T Nikkari
Journal:  Lipids Health Dis       Date:  2009-03-30       Impact factor: 3.876

6.  Parameters of lung inflammation in asthmatic as compared to healthy children in a contaminated city.

Authors:  Benigno Linares Segovia; Gabriela Cortés Sandoval; Norma Amador Licona; Juan Manuel Guízar Mendoza; Estela Núñez Lemus; Diana Olivia Rocha Amador; Xóchitl Sofía Ramírez Gómez; Rebeca Monroy Torres
Journal:  BMC Pulm Med       Date:  2014-07-08       Impact factor: 3.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.